Author

T. D. Allen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Yang· 2 shared D. Yang· 2 shared G. Lv· 2 shared H. Li· 2 shared H. Liu· 2 shared J. Kalashova· 2 shared J. Zhang· 2 shared Q. Shi· 2 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Yang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 3, 2023

Characterization of mitotic phenotypes associated with a MYC synthetic lethal compound

Q. Shi, X. Liu, J. Kalashova…·D. Yang

This paper characterizes mitotic phenotypes caused by a MYC synthetic lethal compound, dimethylfasudil, showing cell cycle arrest, mitotic catastrophe, and segregation anomalies.

DOI 10.1101/2023.04.03.535438

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 29, 2023

An orally bioavailable 4-phenoxy-quinoline compound as a potent AURKB relocation blocker for cancer treatment

D. YANG, J. Li, T. Zhang…·J. Zhang

This paper identifies LXY18, a 4-phenoxy-quinoline compound that blocks AURKB relocalization, showing potent antimitotic activity and oral bioavailability.

DOI 10.1101/2023.01.29.526078

experimental assaycancer & tumor microenvironment

𝕏 PostBluesky